Mariel Umana-Rivas, Evelin Soares de Brito, Letícia Santana da Silva Soares, Geraldo Rubens Ramos de Freitas, Gustavo Queiroz Arimatea, Priscila Dias Gonçalves, Dayani Galato
{"title":"肾移植后受者免疫抑制剂和其他药物的药物相互作用","authors":"Mariel Umana-Rivas, Evelin Soares de Brito, Letícia Santana da Silva Soares, Geraldo Rubens Ramos de Freitas, Gustavo Queiroz Arimatea, Priscila Dias Gonçalves, Dayani Galato","doi":"10.22491/2357-9730.128108","DOIUrl":null,"url":null,"abstract":"Immunosuppressants (ISS) are the most crucial tools used in the therapeutic regimens of transplant recipients. Nevertheless, these drugs are not the only ones adopted by patients; therefore, knowing the possible drug-drug interactions (DDIs) between immunosuppressants and other drugs commonly used in kidney transplant recipients is essential to ensure the effectiveness and safety of treatments. In this way, the objective is analyzing the DDIs between the immunosuppressants and other commonly used medications on kidney transplant adult recipients with active medical records undergoing post-transplant follow-up for 4.4 years (mean).","PeriodicalId":72279,"journal":{"name":"Archives of clinical and biomedical research","volume":"37 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Drug-drug interactions of immunosuppressants and other drugs in kidney post-transplant recipients\",\"authors\":\"Mariel Umana-Rivas, Evelin Soares de Brito, Letícia Santana da Silva Soares, Geraldo Rubens Ramos de Freitas, Gustavo Queiroz Arimatea, Priscila Dias Gonçalves, Dayani Galato\",\"doi\":\"10.22491/2357-9730.128108\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Immunosuppressants (ISS) are the most crucial tools used in the therapeutic regimens of transplant recipients. Nevertheless, these drugs are not the only ones adopted by patients; therefore, knowing the possible drug-drug interactions (DDIs) between immunosuppressants and other drugs commonly used in kidney transplant recipients is essential to ensure the effectiveness and safety of treatments. In this way, the objective is analyzing the DDIs between the immunosuppressants and other commonly used medications on kidney transplant adult recipients with active medical records undergoing post-transplant follow-up for 4.4 years (mean).\",\"PeriodicalId\":72279,\"journal\":{\"name\":\"Archives of clinical and biomedical research\",\"volume\":\"37 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of clinical and biomedical research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22491/2357-9730.128108\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of clinical and biomedical research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22491/2357-9730.128108","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Drug-drug interactions of immunosuppressants and other drugs in kidney post-transplant recipients
Immunosuppressants (ISS) are the most crucial tools used in the therapeutic regimens of transplant recipients. Nevertheless, these drugs are not the only ones adopted by patients; therefore, knowing the possible drug-drug interactions (DDIs) between immunosuppressants and other drugs commonly used in kidney transplant recipients is essential to ensure the effectiveness and safety of treatments. In this way, the objective is analyzing the DDIs between the immunosuppressants and other commonly used medications on kidney transplant adult recipients with active medical records undergoing post-transplant follow-up for 4.4 years (mean).
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
